Cano Health (NYSE:CANO) Given New $1.00 Price Target at Piper Sandler

Cano Health (NYSE:CANO – Get Rating) had its price objective hoisted by Piper Sandler to $1.00 in a research report report published on Tuesday morning, The Fly reports.

Separately, Citigroup reduced their price target on Cano Health from $5.00 to $4.00 in a research report on Friday, May 12th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and one has given a buy rating to the company. According to data from MarketBeat, Cano Health currently has an average rating of Hold and an average target price of $3.64.

Cano Health Trading Up 0.8 %

Cano Health stock opened at $1.28 on Tuesday. The company has a current ratio of 1.63, a quick ratio of 1.63 and a debt-to-equity ratio of 2.06. The business’s fifty day simple moving average is $1.21 and its two-hundred day simple moving average is $1.50. Cano Health has a 12 month low of $0.76 and a 12 month high of $9.75. The company has a market capitalization of $676.07 million, a price-to-earnings ratio of -1.29 and a beta of -0.02.

Cano Health (NYSE:CANO – Get Rating) last announced its quarterly earnings results on Wednesday, March 1st. The company reported $0.18 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.28. The firm had revenue of $680.37 million for the quarter, compared to the consensus estimate of $655.27 million. Cano Health had a positive return on equity of 0.72% and a negative net margin of 7.57%. As a group, equities analysts predict that Cano Health will post -0.3 earnings per share for the current fiscal year.

Insider Activity

In other news, CFO Brian D. Koppy sold 23,591 shares of the stock in a transaction dated Wednesday, April 5th. The stock was sold at an average price of $1.27, for a total value of $29,960.57. Following the transaction, the chief financial officer now directly owns 802,570 shares of the company’s stock, valued at $1,019,263.90. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Corporate insiders own 54.40% of the company’s stock.

Institutional Trading of Cano Health

Hedge funds have recently modified their holdings of the stock. State Street Corp lifted its position in shares of Cano Health by 3.4% in the first quarter. State Street Corp now owns 4,542,095 shares of the company’s stock valued at $4,133,000 after acquiring an additional 149,752 shares in the last quarter. Squarepoint Ops LLC acquired a new stake in shares of Cano Health in the first quarter valued at approximately $648,000. Geode Capital Management LLC increased its holdings in shares of Cano Health by 4.7% in the first quarter. Geode Capital Management LLC now owns 3,179,945 shares of the company’s stock valued at $2,894,000 after purchasing an additional 142,953 shares during the last quarter. Glenview Capital Management LLC acquired a new stake in shares of Cano Health in the first quarter valued at approximately $865,000. Finally, Bayesian Capital Management LP acquired a new stake in shares of Cano Health in the first quarter valued at approximately $122,000. Hedge funds and other institutional investors own 25.56% of the company’s stock.

Cano Health Company Profile

(Get Rating)

Cano Health, Inc provides primary care medical services to its members in the United States and Puerto Rico. It owns and operates medical centers enabled by CanoPanorama, a proprietary population health management technology-powered platform that provides the healthcare providers at its medical centers with a 360-degree view of their members with actionable insights to improve care decisions and member engagement.